The hemostatic changes in active pulmonary tuberculosis

Turkish Journal of Haematology

Volumn 18, Issue 2, 2001, Pages 95-100

  Sezer, M ^a   Ozturk A ^a   Ilvan, A ^a   Ozkan M ^a   Uskent N ^a  

^a Koşuyolu Hava Lojmanlari ^*  (Turkey)

Author keywords

Antithrombin III; Hypercoagulable state; Protein C; Pulmonary tuberculosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 8; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANEMIA; ARTICLE; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; FOLLOW UP; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LEUKOCYTOSIS; LUNG TUBERCULOSIS; MALE; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0034966456     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Venous thrombosis and rifampicin
2. Physician practices in the prevention of venous thromboembolism
3. Interleukin-1 and pathogenesis of the acute-phase response
4. The hypercoaguble states
5. Anticoagulant protein C pathway defective in majority of thrombophilic patients
6. Resistance to activated protein C as a basis for venous thrombosis
7. Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis
8. Cytokines and the Koch phenomenon
9. IL-6 functions as an exocrine hormone in inflammation: Hepatocytes undergoing acute-phase responses require exogenous IL-6
10. Effects of cytokines on the liver
11. Interleukin 1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
12. Plasma fibrinolytic profile in patients with brain tumors
13. Hemostasis in malignancy
14. Coagulation inhibition and activation in pancreatic cancer. Changes during progressive disease
15. Acute-phase response and the hypercauguble State in Pulmonary Tuberculosis
16. Impaired fibrinolysis and risk of thromboembolism
17. Epidemyological characteristics of platelet aggregability
18. Platelet activation and early carotid atherosclerosis: The ARIC Study
19. Spontaneous platelet aggregation in cerebrovascular disease
20. Mutation in blood coagulation factor V associated with resistance to activated protein C
21. Inherited trombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism